GondolaBio
CA - Palo AltoBiotechnology
Focus: GondolaBio is a 5,000+ employee biotechnology company founded in 2024, headquartered in Palo Alto, focused on therapeutics for genetic diseases in rare diseases and oncology.
Profile data last refreshed 2h ago · AI intelligence enriched 2w ago
Employees
5000+
Open Jobs
25+2 this month
Stable — net +2 jobs in 30d
9 added, 7 removed. Backfill posture.
Should You Work at GondolaBio?
AI assessmentGondolaBio presents a high-risk, high-reward opportunity suitable only for early-stage biotech risk-takers; verify funding, pipeline, and financial runway before committing.
Why Work Here
- Established scale with 5,000+ employees provides infrastructure and resources typical of mid-to-large biotech organizations
- Focus on genetic diseases and rare oncology represents high-unmet-need therapeutic areas with potential for premium pricing and patient impact
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for GondolaBio
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.